首页> 美国卫生研究院文献>Gynecologic Oncology Case Reports >Vesical clear cell adenocarcinoma arising from endometriosis: A mullerian tumor indistinguishable from ovarian clear cell adenocarcinoma
【2h】

Vesical clear cell adenocarcinoma arising from endometriosis: A mullerian tumor indistinguishable from ovarian clear cell adenocarcinoma

机译:子宫内膜异位引起的血管透明细胞腺癌:一种苗勒氏瘤与卵巢透明细胞腺癌没有区别

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endometriosis is associated with increased rates of ovarian, particularly clear cell, adenocarcinomas. Malignant transformation of ovarian endometriosis is most common but rare cases have been reported in the bladder, abdominal wall, diaphragm, and rectum. We present the case of a 44-year-old female with vesical clear cell adenocarcinoma arising in a background of endometriosis in the absence of other pelvic endometriosis. The malignancy was diagnosed on transurethral resection of bladder tumor and managed with radical surgery. Histology and immunohistochemical findings were consistent mullerian origin and indistinguishable from similar tumors arising in the female genital tract. Extrapolating from the gynecologic literature, the recommendation was made for adjuvant chemotherapy. Further studies are needed to clarify the optimal treatment paradigm for ovarian and bladder clear cell adenocarcinomas.
机译:子宫内膜异位症与卵巢癌,特别是透明细胞腺癌的发生率增加有关。卵巢子宫内膜异位的恶性转化是最常见的,但在膀胱,腹壁,diaphragm肌和直肠中也有罕见的病例报道。我们目前的情况是,在没有其他骨盆子宫内膜异位症的情况下,在子宫内膜异位症的背景下出现了膀胱透明细胞腺癌的44岁女性。经尿道膀胱肿瘤切除术诊断为恶性,并经根治性手术治疗。组织学和免疫组化发现是一致的苗勒氏起源,与女性生殖道中出现的类似肿瘤没有区别。从妇科文献中推断,建议进行辅助化疗。需要进一步的研究来阐明卵巢和膀胱透明细胞腺癌的最佳治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号